Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

From HCV Partner To Acquirer, BMS Makes $885 M Offer for ZymoGenetics

Sep 07 2010

• By Alex Lash

Related Content

Bristol’s Transformation To Biopharma Business Progresses With Adnexus Buy

Oct 01 2007

In Obtaining Strong Price From BMS, Medarex Also Ameliorates Significant Pipeline Pressure

Jul 29 2009

ZymoGenetics Snags $70M Payout From BMS For Phase II Start Of New Interferon

Oct 27 2009

Bristol-Myers's Grand Ambitions in Oncology

Nov 01 2009

Refocusing ZymoGenetics Cuts Staff, Seeds Pipeline Of Private Startup Firm

May 06 2009

Novo Nordisk Demerges

Sep 01 1999

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window